L-Carnitine and Cardiac Function in Chronic Hemodialysis
نویسندگان
چکیده
منابع مشابه
Hemodynamic stabilizing effects of L-carnitine in chronic hemodialysis patients.
BACKGROUND The effects of L-carnitine on the hemodynamic state of chronic hemodialysis patients have been debated. In order to clarify the effect of administered L-carnitine on cardiac function and hypotensive episodes during the hemodialysis procedure, a randomized double-blind placebo-controlled study was performed for 3 months. METHODS AND RESULTS TWENTY STABLE OUTPATIENTS UNDERGOING HEMOD...
متن کاملDoes L-carnitine improve endothelial function in hemodialysis patients?
BACKGROUND Atherosclerosis is the leading cause of death in hemodialysis patients. These patients are also very prone to L-carnitine deficiency due to kidney disease. In this clinical trial, we investigated the effect of oral L-carnitine on endothelial function of these patients. MATERIALS AND METHODS [corrected] We studied 31 adult chronic hemodialysis patients in our center and divided them...
متن کامل[Combined therapy with L-carnitine and erythropoietin of anemia in chronic kidney failure patients undergoing hemodialysis].
OBJECTIVES The aim of this study was to analyze the influence of combined therapy with L-carnitine and erythropoietin on selected blood morphology parameters in patients treated with hemodialysis and to assess whether combined therapy could decrease the requirement for exogenous erythropoietin. PATIENTS AND METHODS The results of anemia treatment were compared in three groups of patients: 27 ...
متن کاملL-carnitine kinetics in chronic hemodialysis patients: comparison between oral and intravenous supplementation
Introduction: In order to clarify the characteristics of different administration routes and to optimize the dosage, carnitine kinetics was investigated under oral and intravenous supplementation. Methods: Lcarnitine was administered orally (900mg) for 12months, intravenously (1000 mg) for 3months and (500mg) for 3months sequentially in 18 chronic hemodialysis patients. Plasma free and acyl car...
متن کاملLong-term L-Carnitine Administration reduces Erythropoietin Resistance in Chronic Hemodialysis Patients with Thalassemia Minor
BACKGROUND AND AIM Both thalassemia and carnitine deficiency represent independent causes of erythropoietin resistance, and thus anemia, in uremic patients. We evaluated the unknown long-term effects of L-carnitine administration in β-thalassemic on chronic hemodialysis. METHODS We studied twelve subjects (M = 8; F = 4) affected by β-thalassemia minor (β-thal; HbA2 level = 6.6 ± 0.6%) and for...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Open Access Journal of Urology & Nephrology
سال: 2016
ISSN: 2578-4676
DOI: 10.23880/oajun-16000102